DD

Daniel Dan Spira

Mr Spira is the CEO of iNova Pharmaceuticals (since 2017), a leading multinational consumer healthcare and pharmaceutical company with operations across Asia Pacific and Africa. Previously, he was at Bausch Health (2011-2015) as Vice President and GM-North America and was also Managing Director, Pacific region. Prior to that, Dan spent over 15 years at Johnson & Johnson Inc in various roles including Vice President, Country Manager, Chief Marketing Officer and other sales and marketing roles across the Asia Pacific, Europe/Middle East and North American regions. He is Chair of People & Culture Committee.

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
03/05/24752,172N/A0N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
29/03/22
Buy
28,735$0.970$27,872Participation in share purchase plan
28/04/21
Sell
3,487$1.710$5,962As advised by the company
26/04/21
Sell
362,342$1.570$568,876As advised by the company
13/04/21
Exercise
1,040,000$0.550$572,000Exercise of options
13/04/21
Buy
1,040,000$0.550$572,000Exercise of options